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INTRODUCTION
GABAA receptor heterogeneity influences the excitability of spe-
cific neuronal populations and is a major determinant of the
drug sensitivity of different brain regions. For example, the dis-
covery of the δ-GABAAR (Shivers et al., 1989; Wisden et al.,
1992) led to the view that low ambient GABA levels in the
extracellular space (Kekesi et al., 1997; Wu et al., 2007) was
capable of generating a novel form of tonic inhibition in brain
regions that expressed δ-GABAARs (Kaneda et al., 1995; Salin
and Prince, 1996; Brickley et al., 2001; Stell et al., 2003; Drasbek
and Jensen, 2006; Bright et al., 2007; Ade et al., 2008; Kirmse
et al., 2008; Santhakumar et al., 2010). This particular mem-
ber of the GABAA receptor family has attracted clinical inter-
est because the δ-GABAAR orthosteric agonist THIP has been
shown to promote the slow thalamocortical oscillations asso-
ciated with sleep (Faulhaber et al., 1997; Cope et al., 2005;
Winsky-Sommerer et al., 2007). Gene knock-out studies have
further demonstrated that δ-GABAARs are also an important
target for the neurosteroid anesthetic alphaxalone (Mihalek et al.,
1999; Spigelman et al., 2003). The motivation for pharmaco-
logically targeting these δ-GABAAR populations (Brickley and
Mody, 2012) has been further driven by a number of stud-
ies that have associated disruptions in δ-GABAAR activation
with mood disorders (Smith et al., 1998; Maguire et al., 2005;
Maguire and Mody, 2008; Sequeira et al., 2009; Feng et al., 2010),
schizophrenia (Maldonado-Aviles et al., 2009), and epilepsy
(Spigelman et al., 2002; Cope et al., 2009; Macdonald et al.,
2010).
However, the high GABA affinity of δ-GABAARs (Bright et al.,
2011) is such that a low-affinity orthosteric agonist such as
THIP will be displaced from the GABA binding site at low
GABA concentrations (Houston et al., 2012). Therefore, allosteric
modulation of δ-GABAARs by neurosteroids (Mihalek et al.,
1999; Belelli and Herd, 2003; Spigelman et al., 2003; Stell et al.,
2003; Cope et al., 2005) represents a more effective strategy for
enhancing the tonic conductance when ambient GABA levels
in vivo are high (Houston et al., 2012). DS2 is an exogenous
positive allosteric modulator that appears to act at a unique
binding site on the δ-GABAAR (Wafford et al., 2009; Jensen
et al., 2013). Unfortunately, DS2 has little utility from a clinical
perspective due to a poor brain/plasma profile (Jensen et al.,
2013), but DS2 could still prove useful in characterizing the
contribution of δ-GABAARs to tonic and phasic responses. We
are particularly interested in exploring the ability of DS2 to
distinguish the contribution of δ-GABAAR to phasic and tonic
conductance changes. For example, in cerebellar granule cells, the
clear extrasynaptic location of δ-GABAARs (Nusser et al., 1995,
1998) has led to the hypothesis that these high-affinity receptors
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have a role that is both anatomically and functionally distinct
from the lower-affinity synaptic GABAA receptors. Consistent
with this view, no difference in the kinetics of the inhibitory post-
synaptic synaptic conductances (IPSCs) was reported in δ subunit
knockout mice (Bright et al., 2011). However, it has previously
been suggested that GABA spillover from the synaptic cleft may
transiently activate extrasynaptic δ-GABAARs to generate a slow
component to the IPSC decay (Rossi and Hamann, 1998; Hamann
et al., 2002). We have chosen to re-address the involvement
of δ-GABAARs to tonic and phasic conductance changes in a
variety of different cell types of the cerebellum, thalamus and
neocortex. The positive allosteric modulator DS2 was chosen as
the action of this particular drug should only be apparent when
δ-GABAARs are occupied by GABA. Therefore, this drug has
the potential to assay the involvement of functionally relevant
δ-GABAARs in the generation of tonic and phasic conductance
changes.
MATERIALS AND METHODS
ACUTE SLICE PREPARATIONS
Mice were routinely handled to reduce stress levels and brain slices
were then prepared from adult (3–6 months postnatal) C57Bl/6J
mice that were killed by cervical dislocation (in accordance with
UK Home Office guidelines). The brain was rapidly removed and
immersed in ice cold slicing solution. For cerebellar slices the slic-
ing ACSF contained in mM; KCl 2.5, CaCl2 1, MgCl 5, NaH2PO4
1.25, NaHCO3 26, glucose 11, glycerol 250. For thalamic and
cortical slices the slicing solution contained (in mM: NaCl 125,
KCl 2.5, CaCl2 2, MgCl 2, NaH2PO4 1.25, NaHCO3 26, glucose 11,
1 kynurenic acid) pH 7.4 when bubbled with 95% O2/5% CO2.
Slices were cut using a vibratome tissue slicer (Campden instru-
ments) at a thickness of 250 µm and immediately transferred to a
holding chamber containing slicing ACSF continuously bubbled
with 95% O2/5% CO2. Once slicing was complete the holding
chamber was transferred to a 37◦C heat block for 40 min after
which the slicing ACSF was gradually exchanged for recording
ACSF (in mM: NaCl 125, KCl 2.5, CaCl2 2, MgCl 2, NaH2PO4
1.25, NaHCO3 26, glucose 11, pH 7.4 when bubbled with 95%
O2/5% CO2) and allowed to reach room temperature whilst the
solutions were exchanged prior to electrophysiological recording
experiments.
ELECTROPHYSIOLOGY
Slices were visualized using a fixed-stage upright microscope
(BX51W1, Olympus) fitted with a high numerical aperture water-
immersion objective and a digital camera. The recording chamber
was continuously perfused with the appropriate external solution.
Solution entered the bath via a gravity perfusion system at a rate
of 3 ml/min. Patch pipettes were fabricated from thick-walled
borosilicate glass capillaries (1.5 mm o.d., 0.86 mm i.d., Harvard
Apparatus) using a two-step vertical puller (Narishige, PC-10).
Pipette resistances were typically less than 8 M (for granule cells)
and 3–4 M (thalamic and cortical pyramidal cells) when back
filled with internal solution. The internal solution contained (in
mM) CsCl 140, NaCl 4, CaCl2 0.5, HEPES 10, EGTA 5, Mg-ATP
2; the pH was adjusted to 7.3 with CsOH. The identity of each cell
type was determined from location within the slice preparation
and characteristic cell capacitance and input resistance. Biocytin
(1.5 mg/ml) was included in the pipette solution so that neuronal
cell-type could be confirmed from morphological features. For
example, layer II/III pyramidal cells were first identified from their
position in the neocortex and their characteristic cell capacitance
of 125.3 ± 10.3 pF and input resistance of 214.7 ± 29.9 M
(n = 13). Location was later confirmed by comparison with
Nissl staining of neocortical cell body layers and pyramidal cell
morphology was unambiguously established in 7 out of the 13
recorded cells (data not shown). The amplifier headstage was
connected to an Axopatch 200B or 700B amplifier (Molecular
Devices; Foster City, CA). Fine and course movement of the
pipettes were controlled by micromanipulators (PatchStar, Sci-
entifica) mounted upon a fixed platform. The amplifier current
output was filtered at 10 kHz (−3 dB, 8-pole low-pass Bessel)
and digitized at 20 kHz using a National Instruments digitization
board (NI-DAQmx, PCI-6052E; National Instruments, Austin,
Texas). Data acquisition was performed using WINWCP (Version
4.1.2) and WINEDR (Version 3.0.9) kindly provided by John
Dempster (John Dempster; University of Strathclyde, UK).
DRUG APPLICATION
Direct drug application close to cerebellar neurons was performed
with a gravity fed system via an eight unit solenoid driver con-
trolled via TTL pulses produced from the WinEDR software. Up
to eight different solutions flowed into a small diameter manifold
tip placed close to the cell using a manual micromanipulator.
For thalamic and cortical neurons bath application of drugs also
used a gravity perfusion system with a flow rate of 2–3 ml/min
into a total bath volume of ∼2 ml. Solutions were transferred to
the bath via PTFE tubing and were removed from the bath via a
suction line connected to a peristaltic pump (Pharmacia Biotech
P-1). 4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl ben-
zamide (DS2, Tocris Bioscience, Bristol, UK) stock solutions were
prepared so that the final DMSO concentration was less than 0.1%
(Wafford et al., 2009). 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-
3-ol hydrochloride (THIP, Sigma-Aldrich), Terodotoxin (TTX,
Ascent Scientific) SR-95531 (gabazine—Ascent Scientific) and
Kynurenic acid (Sigma-Aldrich) were prepared at the appropriate
concentration in recording ACSF.
DATA ANALYSIS
In order to calculate the tonic conductance, all-point histograms
of the current record were constructed and differences in the
peak amplitude measured from a single Gaussian fit were used
to calculate the amplitude of the standing inward current before
and after DS2 (10 µM) application and also in the presence
of 50–100 µM gabazine. Synaptic events were analyzed using
WinEDR/WinWCP. Event detection was performed using ampli-
tude threshold crossing or scaled template matching. Events were
aligned on their initial rising phases and averaged synaptic wave-
forms were constructed from IPSCs that exhibited monotonic
rises and an uninterrupted decay phase. Average baseline current
levels were calculated during a 10 ms epoch immediately before
each detected event and the peak amplitude was determined rela-
tive to this value. The decay of individual IPSCs was calculated as
the charge transfer during the baseline corrected IPSC divided by
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the IPSC peak amplitude. This allowed a fit-independent estimate
of the decay that could be determined for individual or averaged
IPSCs.
STATISTICAL ANALYSIS
Distributions were compared using Origin 8.5 (Microcal, Cen-
tury City, CA) using unconstrained least-squared fitting proce-
dures, and statistical tests were performed at a 95% confidence
level. Values stated are the mean ± the standard error of the
mean (SEM).
RESULTS
CEREBELLAR GRANULE CELLS
DS2 is expected to enhance the tonic conductance generated
by the persistent activation of high-affinity δ-GABAARs with
little action on IPSCs mediated by conventional synaptic γ-
GABAARs. We initially compared the actions of DS2 with the
more commonly used δ-GABAAR selective orthosteric agonist,
THIP. Changes in tonic and phasic conductance were examined
in adult cerebellar granule cells recorded from acute slice prepa-
rations. Gaussian fits to all-point histograms constructed from
100 ms current epochs were used to examine the time course of
DS2 and THIP actions on the holding current (Figures 1A, B).
From these data the tonic conductance was estimated to be
596 ± 84 pS (n = 7) in control conditions compared to 1631 ±
360 pS (n = 7) in the presence of 10 µM DS2 and 1658 ±
333 pS (n = 6) in the presence of 500 nM THIP. Therefore, the
average tonic conductance recorded in the presence of DS2 and
THIP was not significantly different (unpaired two sample T-
test or Mann-Whitney U-test). The scatter plot of IPSC peak and
decay shown for a single cerebellar granule cell in Figure 1C and
the corresponding all-point histograms constructed from these
distributions illustrates the similarity of the sIPSCs recorded in
the presence and absence of DS2. In 5 cells the average frequency
of sIPSCs was 0.8± 0.3 Hz in control versus 1.0± 0.3 Hz in DS2.
The average sIPSC peak amplitude was 292 ± 50 pS in control
versus 275 ± 36 pS in DS2 and the average decay of sIPSCs was
4.9 ± 0.6 ms in control versus 4.7 ± 0.5 ms in DS2. Therefore, as
shown in Figure 1D, no significant change (paired sample t-tests)
in sIPSC properties was observed in the presence of DS2 although
a clear enhancement of the tonic conductance was observed using
this allosteric modulator.
CEREBELLAR INTERNEURONS
Cerebellar interneurons within the internal granule cell layer
(Golgi cells) do not express high-affinity extrasynaptic δ-
GABAARs and therefore do not exhibit any tonic conductance
(Houston et al., 2012). As expected, no discernible resting tonic
conductance could be measured in these cells and on average
there was no significant tonic conductance associated with the
application of 500 nM THIP (109 ± 69 pS, n = 6) or 10 µM DS2
(184 ± 107 pS, n = 6). The average sIPSC frequency was 9.8 ±
2.1 Hz in control versus 8.9± 1.9 Hz in DS2 (n= 6). The average
sIPSC amplitude was 811± 231 pS in control versus 862± 269 pS
in DS2. The average decay of sIPSCs was 8.3 ± 0.9 ms in control
versus 8.5± 0.9 ms in DS2. Once again none of these changes were
significant (paired sample t-tests). Therefore, it is clear that DS2,
FIGURE 1 | DS2 application to cerebellar granule cells enhances the
tonic conductance but does not alter IPSC properties. (A) All-point
histograms were constructed from 100 ms current traces (VH −60 mV)
recorded from a cerebellar granule cell in control conditions and in the
presence of 10 µM DS2 and 500 nM THIP and the solid lines are Gaussian
fits to the distributions. (B) The time course plot illustrates the change in
average holding current calculated every 1 s from consecutive 100 ms
current epoch. An enhancement of the tonic conductance was observed
during DS2 and THIP applications. (C) Scatter plot of peak amplitude against
decay time for all IPSCs recorded from this granule cell in the presence
(filled squares, grey) and absence (filled circles, black) of DS2. The
histograms on each axis illustrate Gaussian fits to the distributions
constructed in the presence and absence of DS2. (D) Scatter plot of the
average tonic conductance and average sIPSC decay before and after DS2
application. The data for individual cells are linked by dashed lines and
arrows to illustrate the consistent increase in the tonic conductance that
takes place with no consistent change in the IPSC decay. Superimposed on
this plot are the average values across all cells (mean ± SEM, n = 5).
at the dose used in this study, does not influence conventional γ
subunit-containing synaptic GABAA receptors of the cerebellum.
THALAMIC RELAY NEURONS OF THE dLGN
The ability of DS2 to selectively modulate the tonic conduc-
tance with little action on phasic inhibition has previously been
reported for thalamic relay neurons recorded from the ventrobasal
thalamus (Wafford et al., 2009). However, it is well known that
in rodents the visual thalamus (dLGN) is the only thalamic relay
nucleus to contain GABAergic interneurons (Ohara et al., 1983)
and, therefore, it was important to establish whether DS2 actions
would be similar in these two nuclei. Also, in our previous studies
(Bright et al., 2007) we have demonstrated the presence of slow
rising and slow decaying IPSCs in X-type relay neurons of the
dLGN. Therefore, we first examined the actions of DS2 on fast
and slow IPSCs recorded from dLGN thalamic relay neurons.
As shown in Figure 2A, 10 µM DS2 did not influence the
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FIGURE 2 | DS2 enhances the tonic conductance recorded from dLGN
thalamic relay neurons but does not alter IPSC properties.
(A) Scatter-plots of individual IPSC peak amplitude (pA) and 10–90%
rise-time (ms) recorded from a dLGN thalamic neuron (VH −70 mV) in the
absence (control) and presence of 10 µM DS2. (B) Time course of the
average holding current calculated every 1 s from consecutive 100 ms
current epochs during the application of 10 µM DS2 and 100 µM gabazine.
(C) Scatter plot of the average tonic conductance and average sIPSC decay
before and after DS2 application. The data for individual cells are linked by
dashed lines and arrows to illustrate the consistent increase in the tonic
conductance that took place with no consistent change in the estimated
IPSC decay. Superimposed on this plot are the average values across all
cells (mean ± SEM, n = 4).
distribution of fast or slow IPSCs recorded from a dLGN relay
neuron. Indeed, the average decay of sIPSCs was unchanged with
a decay of 8.4 ± 0.6 ms in control conditions vs. 9.2 ± 1.2 ms
in DS2. The average sIPSC amplitude was also 743 ± 137 pS in
control vs. 689 ± 137 pS in DS2. The average sIPSC frequency
was 8.6 ± 2.9 Hz in control vs. 7.1 ± 2.3 Hz in DS2 (n = 4). The
tonic conductance in thalamic relay neurons was 212 ± 47 pS (n
= 4) in control conditions and increased to 1319 ± 263 pS in the
presence of 10µM DS2 (Figure 2B). The scatter plot in Figure 2C,
illustrates the robust increase in the magnitude of the tonic
conductance measured in all dLGN relay neurons with no con-
sistent change in the decay of the IPSCs recorded from the same
cells. Therefore, the increase in the tonic conductance was not
associated with any significant change in the properties of sIPSCs.
NEOCORTICAL LAYER II/III PYRAMIDAL CELLS
We also analyzed the actions of DS2 on the phasic and tonic
conductance changes in layer II/III cortical neurons. Figure 3A
illustrates the enhancement of the holding current produced by
DS2 application. On average, the tonic conductance was 210± 50
pS (n = 7) in control conditions increasing to 928 ± 181 pS (n =
7) in the presence of DS2 (p = 0.006). However, in contrast to
other cell types, the properties of sIPSCs were significantly altered
FIGURE 3 | DS2 enhances the tonic conductance and also prolongs the
IPSC decay in layer II/III pyramidal neocortical neurons. (A) Plot of the
average holding current (VH −70 mV) calculated every 1 s from consecutive
100 ms epochs (grey circles). The application of 10µM DS2 is indicated by
the solid black bar. (B) Representative IPSCs detected in control conditions
and during DS2 application. (C) Average synaptic waveform constructed
from control data and in the presence of DS2. A simple subtraction of these
traces has been performed to illustrate the slow rising and slow decaying
DS2-sensitive component of the IPSC (grey line). The dashed line indicates
the normalised baseline. (D) Scatter plot of the tonic conductance against
the IPSC decay for each cell (grey circles) before and after DS2 application
(joined by dashed line and arrow). Superimposed on this plot are the
average values across all cells (mean ± SEM, n = 7).
by DS2 application in these neocortical neurons. In Figure 3B, we
have plotted representative examples of IPSCs that were recorded
in the presence and absence of DS2. On average, the 10–90% rise-
time (1.7 ± 0.1 ms vs. 1.7 ± 0.1 ms) and the peak amplitude
(720 ± 46 pS vs. 677 ± 43 pS) did not alter but, the IPSC
frequency significantly reduced from 8.9± 0.4 Hz to 7.8± 0.5 Hz
in the presence of DS2 (p = 0.002) (n = 13). More importantly,
the IPSC decay was 12.6 ± 0.6 ms (n = 13) in control conditions
compared to 15.0 ± 0.7 ms in the presence of 10 µM DS2 (p <
0.001, n = 13, paired sample t-tests). This significant change in
the decay of IPSCs is illustrated further in Figure 3C with the
superimposition of average waveforms normalized to peak ampli-
tude. A simple subtraction of these two waveforms illustrates how
the presence of DS2 is associated with prolongation of the IPSC
decay. The scatter plot in Figure 3D highlights the consistent
change that occurs in both the tonic and phasic conductance
following application of 10 µM DS2. In contrast to the data
illustrated in Figure 2C we observe a consistent increase in both
the tonic conductance and the IPSC decay recorded from all layer
II/III neocortical neurons.
DS2 ACTIONS AND REDUCED GABA RELEASE
It is conceivable that superimposition of IPSCs is contributing to
the changes in decay kinetics we have observed in recordings from
neocortical neurons. In an attempt to reduce this confounding
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issue we blocked action potential dependent GABA release with
the voltage-gated sodium channel blocker TTX and analyzed the
properties of miniature IPSCs (mIPSCs) that occur at a lower
frequency. The average frequency of mIPSCs was indeed reduced
to 3.7 ± 0.6 Hz (n = 8) in the presence of TTX compared to
8.9 ± 0.4 Hz (n = 13) in normal recording conditions. However,
the ability of DS2 to enhance the tonic conductance was much
reduced in the presence of TTX. The average tonic conductance
was 190 ± 49 pS in control conditions compared to 302 ± 60
pS in DS2 (n = 8; p = 0.01 paired t-tests). For comparison,
in normal recording conditions the DS2 induced enhancement
of the tonic conductance was 733 ± 186 pS (n = 7) but this
enhancement was only 112± 32 pS (n= 8) in the presence of TTX
(Figure 4A). Therefore, consistent with the view that DS2 is an
allosteric modulator of δ-GABAARs, the ability of this particular
drug to enhance the tonic conductance appears to be dependent
upon the degree of receptor occupancy.
The ability of DS2 to prolong the decay of IPSCs was still
evident in the presence of TTX. Figure 4B illustrates the superim-
position of mIPSCs recorded in the presence and absence of DS2.
Once again there was a small but significant change in the decay
of the IPSCs. On average IPSC decay was significantly prolonged
from 9.7 ± 1.1 ms in control to 11.1 ± 1.3 ms in the presence of
DS2 (n= 8; p= 0.04 paired T-test) but all other IPSC parameters
were unaltered. The IPSC frequency was 3.7 ± 0.6 Hz in control
and 3.8 ± 0.6 Hz in the presence of DS2. The 10–90% rise time
was 1.2± 0.08 ms in control and 1.3± 0.09 ms in DS2. The peak
conductance of IPSCs was 551.1± 24.1 pS in control compared to
536.1 ± 19.5 pS in the presence of DS2. The prolongation of the
IPSC decay is also evident in Figure 4C with the superimposition
of normalized average waveforms recorded in the presence and
absence of DS2 along with the subtracted waveform. The scatter
plot in Figure 4D demonstrates how the prolongation of the IPSC
decays was apparent in all but one cell and a small but significant
increase in tonic conductance was also associated with each of
these recordings.
DISCUSSION
δ-GABAARs CONTRIBUTE DIFFERENTLY TO PHASIC AND TONIC
CONDUCTANCE CHANGES IN CEREBELLUM, THALAMUS AND
NEOCORTEX
This study demonstrates that DS2 induces a robust enhancement
of the tonic conductance in cerebellar granule cells, dLGN tha-
lamic relay neurons and layer II/III neocortical pyramidal cells.
These cell types were specifically chosen as they are known to
express high-affinity δ-GABAARs and are, therefore, capable of
responding to the low resting ambient GABA concentrations
present in the extracellular space to generate a tonic conductance
(Brickley and Mody, 2012). In the cerebellum and thalamus the
actions of DS2 are clearly restricted to the tonic conductance with
no significant alterations in the properties of IPSCs. However,
this was not the case for layer II/III neocortical pyramidal cells
where a small but consistent slowing of the IPSC decay was
apparent. DS2 prolonged the average decay of IPSCs by 20 ±
2% (n = 13) in normal recording conditions and by 14 ± 5%
(n = 8) in the presence of TTX. The contribution of δ-GABAARs
to IPSCs could indicate that δ-GABAARs are physically closer to
FIGURE 4 | Enhancement of the tonic conductance by DS2 in layer II/III
cortical neurons is attenuated in conditions of reduced GABA release
whilst still significantly increasing the IPSC decay. (A) Plot of the
average holding current calculated every 1 s from consecutive 100 ms
epochs (grey circles) recorded from a cortical neuron during a 10 µM DS2
application followed by application of 100 µM gabazine in the continuous
presence of the sodium channel blocker TTX (500 nM). (B) Representative
mIPSCs recorded in control conditions and after DS2 application from a
single cell. Dashed line indicates the normalised baseline. (C)
Representative trace of average IPSCs recorded in the presence of TTX
before and after DS2 application and the subtracted waveform (grey line).
Dashed line indicates the normalized baseline. (D) Scatter plot of the
average tonic conductance and the IPSC decay before and after DS2
application (dotted arrow) for each cell examined (grey circles) and also the
average data for all cells (mean ± SEM, n = 8).
GABA release sites in neocortical neurons or that those barriers
to GABA diffusion may be less in the neocortex compared to
the thalamus and cerebellum. We have previously suggested that
receptor desensitization associated with high-affinity δ-GABARs
could render these receptors unresponsive to brief changes in
GABA concentration at or near the synaptic cleft (Bright et al.,
2011). Our present results indicate that neocortical δ-GABAARs
could be available for activation by brief changes in GABA
concentration in layer II/III at least. However, more detailed infor-
mation on resting GABA concentrations, δ-GABAAR anatom-
ical location, and functional properties of GABA transporters
are obviously required. DS2 is an allosteric modulator and its
mechanism of action may well involve a reduction in the steady-
state desensitization of δ-GABAARs. Assuming that drug access
is also similar in the different tissues, it is also conceivable
that differences in GABA affinity/efficacy are influencing DS2
action or that allosteric modulation by DS2 varies according
to the δ-GABAAR type expressed. However, a more detailed
anatomical description of δ-GABAAR subunit localization in the
neocortex will be required before this receptor type can be con-
sidered a purely extrasynaptic receptor population in all brain
regions.
The extrasynaptic location of δ-GABAARs has been firmly
established for cerebellar granule cells (Nusser et al., 1998) and
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it is also clear that the decay of IPSCs was not altered when
the δ subunit is genetically removed from granule cells (Bright
et al., 2011). This would appear to contradict earlier studies that
discuss the recruitment of high-affinity δ-GABAARs following
GABA spillover in cerebellar granule cells (Hamann et al., 2002).
This was based upon interpreting neurosteroid insensitivity of
IPSCs as evidence for the involvement of the δ subunit whereas
it is now clear from a number of studies that δ-GABAARs are
highly sensitive to neurosteroid modulation (Stell et al., 2003;
Herd et al., 2007). We have previously reported that δ-GABAARs
are heavily desensitised in the presence of GABA and as such
may be insensitive to GABA that has escaped from the immediate
vicinity of the synapse (Bright et al., 2011). In the current study
we report that DS2 has no actions on IPSC kinetics in cerebellar
granule cells suggesting that synaptic release of GABA does not
activate δ-GABAARs in the cerebellum. This would also appear
to be the case for thalamic relay neurons of the dLGN where
DS2 also only enhanced the tonic conductance. This result is
consistent with previous studies using DS2 in the ventrobasal
thalamus (Wafford et al., 2009) and the lack of a significant change
in sIPSCs in the ventrobasal thalamus of the δ -/- mouse (Porcello
et al., 2003).
The extrasynaptic location of δ-GABAARs has also been estab-
lished for dentate gyrus granule cells of the mouse hippocampus
(Wei et al., 2003) where δ-GABAARs have been identified at the
edge of synapses in the molecular layer. At room temperature,
the IPSC decay in δ -/- mice (Wei et al., 2003) was altered and
the contribution of δ-GABAARs to the IPSC decay was further
confirmed with another δ-GABAAR positive allosteric modulator
(Vardya et al., 2012). This particular drug, AA29504, was reported
to prolong the IPSC decay in dentate granule cells but, the
tonic conductance was only enhanced in the presence of THIP.
This may suggest that the extrasynaptic δ-GABAARs were not
occupied by GABA in the control conditions of these experiments.
AA29504 also had little action on the tonic or phasic conductance
recorded in layer II/III neocortical neurons (Hoestgaard-Jensen
et al., 2010). However, a slow rising and slow decaying IPSC
(GABAA,slow) recorded from layer II/III neurons of the neocortex
has been reported to involve δ-GABAAR activation in response to
GABA released from neurogliaform cells (Szabadics et al., 2007;
Olah et al., 2009). The neurosteroid THDOC, at concentrations
believed to be selective for δ-GABAARs, was shown to prolong
the GABAA,slow and enhance the tonic conductance mediated
by δ-GABAARs (Szabadics et al., 2007; Olah et al., 2009). Neu-
rogliaform axonal varicosities are not found in close opposition
to classical inhibitory synapses and the GABA released from these
sites is proposed to diffuse to extrasynaptic GABAARs. The IPSCs
recorded in our study exhibited fast rise and decay times that
are more consistent with conventional synaptic release mech-
anisms. Therefore, conventional fast inhibitory synaptic trans-
mission may also involve δ-GABAARs activation in layer II/III
neocortex.
DS2 ACTIONS AS A FUNCTION OF RECEPTOR TYPE AND RECEPTOR
OCCUPANCY
As a negative control we also recorded from cerebellar Golgi
cells that are situated in the internal granule cell layer and,
therefore, experience a similar level of ambient GABA to cere-
bellar granule cells (Houston et al., 2012). Consistent with
the absence of δ-GABAARs a DS2-induced conductance was
absent from cerebellar Golgi cells. Initial recombinant expres-
sion data (Wafford et al., 2009) demonstrated that DS2 does
not have any direct actions on δ-GABAARs but results in an
enhanced maximum response to GABA with little change in
GABA potency. A later study Jensen et al. (2013) suggested
that this positive allosteric modulation involves DS2 binding
to a novel site on the δ-GABAAR. This interpretation relies
on the observation that DS2 enhancement still occurs in the
presence of drugs that are known to bind the known orthos-
teric and allosteric binding sites. Additionally, loss of function
mutations in the etomidate and neurosteroid binding site did
not interfere with DS2 actions. Future studies using alternative
techniques such as photolabelling will be required to establish
if the actions of DS2 do indeed reflect binding to a previously
unidentified site on the δ-GABAAR. Unfortunately, the thera-
peutic potential of DS2 is hindered by its poor brain penetra-
tion in vivo but, our observations on native receptors clearly
demonstrate the utility of targeting the DS2 site as a strategy
for enhancing tonic inhibition in brain regions that express
δ-GABAARs.
Based upon in situ hybridization and immunohistochemical
data the subunit identity of the extrasynaptic δ-GABAARs in
cerebellar granule cells are of the α1/β2/β3/δ, α6/β2/β3/δ or
α1/α6/β2/β3/δ type. Therefore, the ability of DS2 to enhance the
tonic conductance is not greatly influenced by the α subunit
identity. Indeed, the magnitude of the DS2-induced conductance
was 1113 ± 366 pS (n = 7) in cerebellar granule cells (α6-
containing), compared to 1107 ± 233 pS (n = 4) in dLGN
thalamic relay neurons and 733 ± 186 pS (n = 7) in layer II/III
neocortical pyramidal cells (α4-containing). However, cerebellar
granule cells are considerably smaller than thalamic and cortical
neurons. For example, using whole-cell measurements of cell
capacitance, and assuming a specific membrane capacitance of
1 µF/cm2, the estimated membrane area for cerebellar granule
cells is only 386 ± 30 µm2 (n = 7), compared to 10,081 ±
712 µm2 (n = 26) for thalamic relay neurons and 11,909 ±
835 µm2 (n = 29) for layer II/III neocortical pyramidal cells.
The density of extrasynaptic GABAA receptors is known to be
fairly similar in cerebellar granule cells and neocortical pyramidal
cells (Nusser et al., 1998; Kasugai et al., 2010). Therefore, it is
rather surprising that cerebellar granule cells have a similar mag-
nitude of DS2-induced conductance but this result may reflect
a low level of δ-GABAAR occupancy (Houston et al., 2012).
Indeed, in the presence of TTX the DS2-induced conductance
was much reduced compared to normal recording conditions
further suggesting that DS2-enhancement of the tonic conduc-
tance is dependent upon receptor occupancy. The result of this,
and other studies, suggests that positive allosteric modulation
of tonic inhibition via a DS2-like binding site will have distinct
benefits as a strategy for enhancing tonic inhibition in the brain.
In many, but not all, brain regions DS2-like binding will selec-
tively enhance the tonic conductance and any resulting allosteric
modulation will be limited to δ-GABAARs that are occupied
by GABA.
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